R. Andrew Sewell MD
Assistant Professor of Psychiatry
Selected Publications
- Sewell RA, Petrakis IL. “Does Gamma-Hydroxybutyrate (GHB) Have a Role in the Treatment of Alcoholism?” Alcohol and Alcoholism 2011, 46(1): 1-2.
- Ahn K, Gil R, Seibyl J, Sewell RA, D’Souza, DC. “Probing GABA Receptor Function in Schizophrenia with Iomazenil”. Neuropsychopharmacology 2010, 10 November, 1-7.
- Sewell RA, Poling J, Sofuoglu M. “The Effect of Cannabis Compared with Alcohol on Driving”. American Journal on Addictions 2009; 18: 1-9.
- Sewell RA, Perry EB, Karper LP, Bell MD, Lysaker P, Goulet JL, Brenner L, Erdos J, D’Souza DC, Seibyl JP, Krystal JH. “Clinical Significance of Neurological Soft Signs in Schizophrenia: Factor Analysis of the Neurological Evaluation Scale”. Schizophrenia Research 2010 Dec; 124(1-3): 1-12.
- Sewell RA, Skosnik PD, Garcia-Sosa I, Ranganathan M, D’Souza DC. “Behavioral, cognitive and psychophysiological effects of cannabinoids: relevance to psychosis and schizophrenia”. Rev Bras Psiquiatr. 2010 May;32 Suppl 1:515-30.
- Sewell RA, Ranganathan M, D’Souza DC. Cannabinoids and Psychosis. International Review of Psychiatry 2009; 21(2): 152-162.
- Sofuoglu M, Sewell RA. “Norepinephrine and Stimulant Addiction”. Addiction Biology 2008; 14(2): 119-129.
- Sewell RA, Halpern JH, Pope HG Jr. “Response of Cluster Headache to Psilocybin and LSD”. Neurology 2006; 66: 1920-1922.
- Sewell RA, Johnson D, Fellows D. Cluster headache associated with Moyamoya. Journal of Headache and Pain 2009; 10(1): 69.
- Sewell RA, Halpern JH. “Response of Cluster Headache to Psilocybin and LSD”. In: Winkelman MJ, Roberts TB, editors. Psychedelic Medicine: New Evidence for Hallucinogenic Substances as Treatments. New York: Greenwood Publishing Group, 2007.
